ProtoKinetix Announces Share Issuance
April 02 2015 - 2:42PM
Business Wire
ProtoKinetix, Incorporated (OTC: PKTX) (the "Company" or
"Protokinetix") (www.protokinetix.com) is pleased to announce that
it has completed a private placement (the “Offering”) for gross
proceeds of $125,000. The Company has issued 2,500,000 shares of
common stock at a price of $0.05 per share. One of the purchasers
under the Offering is the President and Chief Executive Officer of
the Company, Clarence E. Smith, who invested $75,000 for the
purchase of 1,500,000 shares of common stock of the Company.
The securities offered pursuant to the Offering will not be
registered under the United States Securities Act of 1933 (the
“Securities Act”) and may not be offered or sold in the United
States absent registration or an applicable exemption from the
registration requirements of the Securities Act.
About ProtoKinetix
ProtoKinetix, Inc. is a molecular biotechnology company that has
developed and patented a family of hyper stable, potent
glycopeptides (AAGP™) that dramatically enhance therapeutic results
and reduce the cost of stem cell medicine. Due to the
anti-inflammatory effect of AAGP™ molecules, the Company is
currently targeting the direct treatment of diseases that have a
major inflammatory component.
This press release shall not constitute an offer of securities
in the United States or any other jurisdiction. The securities that
may be issued pursuant to this press release are not currently
qualified by prospectus or registered under the U.S. Securities Act
of 1933, as amended (the “Securities Act”), or the laws of any
state, and may not be offered or sold in the United States, or to,
or for the account or benefit of United States persons (as defined
in Regulation S under the Securities Act) or persons in the United
States absent registration or an applicable exemption from the
registration requirements. The securities are subject to resale
restrictions under applicable securities laws.
Clarence E. Smith – President and CEO
ProtoKinetix, Inc.Clarence E. Smith, President & Chief
Executive Officer304-299-5070csmith@protokinetix.com
Protokinetix (PK) (USOTC:PKTX)
Historical Stock Chart
From Oct 2024 to Nov 2024
Protokinetix (PK) (USOTC:PKTX)
Historical Stock Chart
From Nov 2023 to Nov 2024